GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Inventory-to-Revenue

Nortem Biogroup (XPAR:MLBIO) Inventory-to-Revenue : 0.45 (As of Dec. 2022)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Nortem Biogroup's Average Total Inventories for the quarter that ended in Dec. 2022 was €3.13 Mil. Nortem Biogroup's Revenue for the six months ended in Dec. 2022 was €6.98 Mil. Nortem Biogroup's Inventory-to-Revenue for the quarter that ended in Dec. 2022 was 0.45.

Nortem Biogroup's Inventory-to-Revenue for the quarter that ended in Dec. 2022 increased from Dec. 2021 (0.32) to Dec. 2021 (0.45)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Nortem Biogroup's Days Inventory for the six months ended in Dec. 2022 was 1,017.58.

Inventory Turnover measures how fast the company turns over its inventory within a year. Nortem Biogroup's Inventory Turnover for the quarter that ended in Dec. 2022 was 0.18.


Nortem Biogroup Inventory-to-Revenue Historical Data

The historical data trend for Nortem Biogroup's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Inventory-to-Revenue Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22
Inventory-to-Revenue
0.32 0.45

Nortem Biogroup Semi-Annual Data
Dec21 Dec22
Inventory-to-Revenue 0.32 0.45

Competitive Comparison of Nortem Biogroup's Inventory-to-Revenue

For the Packaged Foods subindustry, Nortem Biogroup's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nortem Biogroup's Inventory-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nortem Biogroup's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nortem Biogroup's Inventory-to-Revenue falls into.



Nortem Biogroup Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nortem Biogroup's Inventory-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Inventory-to-Revenue (A: Dec. 2022 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2021 ) + Total Inventories (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )
=( (2.168 + 4.088) / 2 ) / 6.983
=3.128 / 6.983
=0.45

Nortem Biogroup's Inventory-to-Revenue for the quarter that ended in Dec. 2022 is calculated as

Inventory-to-Revenue (Q: Dec. 2022 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Dec. 2021 ) + Total Inventories (Q: Dec. 2022 )) / count ) / Revenue (Q: Dec. 2022 )
=( (2.168 + 4.088) / 2 ) / 6.983
=3.128 / 6.983
=0.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nortem Biogroup  (XPAR:MLBIO) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Nortem Biogroup's Days Inventory for the six months ended in Dec. 2022 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2022 )/Cost of Goods Sold (Q: Dec. 2022 )*Days in Period
=3.128/0.561*365 / 2
=1,017.58

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Nortem Biogroup's Inventory Turnover for the quarter that ended in Dec. 2022 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2022 ) / Average Total Inventories (Q: Dec. 2022 )
=0.561 / 3.128
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nortem Biogroup Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Nortem Biogroup (XPAR:MLBIO) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines